PerTurboID, a targeted in situ method reveals the impact of kinase deletion on its local protein environment in the cytoadhesion complex of malaria-causing parasites.
P. falciparum
cell biology
host–pathogen interaction
infectious disease
malaria
mass-spectrometry
microbiology
parasitic diseases
phosphoregulation
protein kinases
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
22 09 2023
22 09 2023
Historique:
received:
23
01
2023
accepted:
21
09
2023
medline:
11
10
2023
pubmed:
22
9
2023
entrez:
22
9
2023
Statut:
epublish
Résumé
Reverse genetics is key to understanding protein function, but the mechanistic connection between a gene of interest and the observed phenotype is not always clear. Here we describe the use of proximity labeling using TurboID and site-specific quantification of biotinylated peptides to measure changes to the local protein environment of selected targets upon perturbation. We apply this technique, which we call PerTurboID, to understand how the Enzymes known as protein kinases regulate a huge variety of biological processes inside cells by attaching small tags known as phosphate groups onto specific locations on certain proteins. For example, the parasite that causes malaria infections in humans and great apes, injects a protein kinase called FIKK4.1 into certain cells in its host. This enzyme then adds phosphate groups to various parasite and host proteins that, in turn, causes them to form a large group of proteins (known as the cytoadhesion complex) to protect the parasite from being cleared by the hosts’ immune defences. However, it remains unclear how and where the complex forms, and how the parasite regulates it. Proximity labelling is a well-established method that allows researchers to label and identify proteins that are near to a protein of interest. To investigate how the FIKK4.1 enzyme alters host cells to make the cytoadhesion complex, Davies et al. combined proximity labelling with methods that disturb the normal state of cells at a specific timepoint during development. The team used this new approach – named PerTurboID – to identify the proteins surrounding three components in the cytoadhesion complex. This made it possible to create a map of proteins that FIKK4.1 is likely to modify to build and control the cytoadhesion complex. Further experiments examined what happened to these surrounding proteins when FIKK4.1 was inactivated. This revealed that some protein targets of FIKK4.1 become either more or less accessible to other enzymes that attach a molecule known as biotin to proteins. This could be a result of structural changes in the cytoadhesion complex that are normally regulated by the FIKK4.1 kinase. In the future, PerTurboID may be useful to study how genetics or environmental changes affect other groups of proteins within specific environments inside cells, such as protein complexes required for DNA replication or cell division, or assembly of temporal structures required for cell movement.
Autres résumés
Type: plain-language-summary
(eng)
Enzymes known as protein kinases regulate a huge variety of biological processes inside cells by attaching small tags known as phosphate groups onto specific locations on certain proteins. For example, the parasite that causes malaria infections in humans and great apes, injects a protein kinase called FIKK4.1 into certain cells in its host. This enzyme then adds phosphate groups to various parasite and host proteins that, in turn, causes them to form a large group of proteins (known as the cytoadhesion complex) to protect the parasite from being cleared by the hosts’ immune defences. However, it remains unclear how and where the complex forms, and how the parasite regulates it. Proximity labelling is a well-established method that allows researchers to label and identify proteins that are near to a protein of interest. To investigate how the FIKK4.1 enzyme alters host cells to make the cytoadhesion complex, Davies et al. combined proximity labelling with methods that disturb the normal state of cells at a specific timepoint during development. The team used this new approach – named PerTurboID – to identify the proteins surrounding three components in the cytoadhesion complex. This made it possible to create a map of proteins that FIKK4.1 is likely to modify to build and control the cytoadhesion complex. Further experiments examined what happened to these surrounding proteins when FIKK4.1 was inactivated. This revealed that some protein targets of FIKK4.1 become either more or less accessible to other enzymes that attach a molecule known as biotin to proteins. This could be a result of structural changes in the cytoadhesion complex that are normally regulated by the FIKK4.1 kinase. In the future, PerTurboID may be useful to study how genetics or environmental changes affect other groups of proteins within specific environments inside cells, such as protein complexes required for DNA replication or cell division, or assembly of temporal structures required for cell movement.
Identifiants
pubmed: 37737226
doi: 10.7554/eLife.86367
pii: 86367
pmc: PMC10564455
doi:
pii:
Substances chimiques
Protozoan Proteins
0
Phosphotransferases
EC 2.7.-
Peptides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : CC2132
Pays : United Kingdom
Organisme : Wellcome Trust
ID : CC0199
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CC2132
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CC0199
Pays : United Kingdom
Organisme : Medical Research Council
ID : CC2132
Pays : United Kingdom
Organisme : Medical Research Council
ID : CC0199
Pays : United Kingdom
Informations de copyright
© 2023, Davies et al.
Déclaration de conflit d'intérêts
HD, HB, MB, JD, MT No competing interests declared
Références
Cell Microbiol. 2012 Nov;14(11):1784-95
pubmed: 22925632
Mol Microbiol. 2003 Nov;50(4):1215-27
pubmed: 14622410
Nature. 2009 Jun 18;459(7249):945-9
pubmed: 19536257
Mol Microbiol. 2007 Jan;63(2):335-47
pubmed: 17176260
Nature. 2017 Dec 7;552(7683):101-105
pubmed: 29186116
Cell. 2021 Jan 21;184(2):545-559.e22
pubmed: 33357446
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11825-9
pubmed: 12177447
Cell. 1997 Apr 18;89(2):287-96
pubmed: 9108483
Sci Rep. 2017 Jun 20;7(1):3881
pubmed: 28634346
PLoS One. 2011;6(5):e20270
pubmed: 21625526
Brief Funct Genomics. 2019 Sep 24;18(5):281-289
pubmed: 31365053
Nat Rev Neurosci. 2013 Jan;14(1):38-48
pubmed: 23254192
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35):
pubmed: 34446549
Elife. 2017 Feb 21;6:
pubmed: 28221136
PLoS One. 2014 Jul 25;9(7):e103272
pubmed: 25062022
Mol Biochem Parasitol. 2003 Nov;132(1):17-26
pubmed: 14563533
Nat Methods. 2017 Apr;14(4):450-456
pubmed: 28288121
Traffic. 2009 Feb;10(2):137-52
pubmed: 19054387
PLoS Pathog. 2022 Aug 5;18(8):e1009882
pubmed: 35930605
Mol Microbiol. 2013 May;88(4):687-701
pubmed: 23489321
Cell. 2008 Jul 11;134(1):48-61
pubmed: 18614010
Sci Rep. 2020 Mar 11;10(1):4548
pubmed: 32161335
Nat Biotechnol. 2020 Mar;38(3):365-373
pubmed: 31819260
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531
pubmed: 36408920
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Blood. 2006 Jul 1;108(1):370-8
pubmed: 16507777
FASEB J. 2014 Jul;28(7):3103-13
pubmed: 24706359
J Proteome Res. 2018 Feb 2;17(2):759-769
pubmed: 29249144
Commun Biol. 2022 Nov 28;5(1):1305
pubmed: 36437406
Genome Biol. 2014;15(12):550
pubmed: 25516281
Malar J. 2015 Jul 16;14:274
pubmed: 26173856
J Biol Chem. 2016 Dec 9;291(50):26188-26207
pubmed: 27777305
Cell Microbiol. 2021 Aug;23(8):e13332
pubmed: 33774908
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
PLoS One. 2016 Jun 22;11(6):e0157873
pubmed: 27332706
Nucleic Acids Res. 2009 Jan;37(Database issue):D539-43
pubmed: 18957442
Nat Microbiol. 2020 Jun;5(6):848-863
pubmed: 32284562
Nat Methods. 2017 Dec;14(12):1167-1170
pubmed: 29039416
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Elife. 2021 Jan 04;10:
pubmed: 33393463
Nature. 2000 Aug 31;406(6799):1001-5
pubmed: 10984055
Science. 2014 Oct 3;346(6205):1255784
pubmed: 25278616
PLoS Pathog. 2010 Sep 02;6(9):e1001083
pubmed: 20824088
Int J Parasitol. 2014 Apr;44(5):319-28
pubmed: 24530877
Sci Rep. 2019 Feb 25;9(1):2664
pubmed: 30804381
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Sci Rep. 2016 Feb 19;6:21800
pubmed: 26892670
Sci Rep. 2015 Mar 02;5:8617
pubmed: 25726759
Mol Biochem Parasitol. 2000 Nov;111(1):107-21
pubmed: 11087921
PLoS One. 2010 Jul 23;5(7):e11747
pubmed: 20668526
Nucleic Acids Res. 2022 Jan 7;50(D1):D898-D911
pubmed: 34718728
Mol Biochem Parasitol. 1988 Dec;31(3):223-31
pubmed: 3065643
Neurodegener Dis. 2008;5(2):55-9
pubmed: 18182779
Blood. 2014 Nov 27;124(23):3459-68
pubmed: 25139348
Nat Med. 2015 Apr;21(4):314-7
pubmed: 25751816
Blood. 2016 Jan 21;127(3):343-51
pubmed: 26637786
PLoS One. 2015 Oct 29;10(10):e0141729
pubmed: 26513658
FASEB J. 2014 Oct;28(10):4420-33
pubmed: 24983468
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3497-502
pubmed: 8622965
Nat Biotechnol. 2018 Oct;36(9):880-887
pubmed: 30125270
J Cell Sci. 2005 Jun 1;118(Pt 11):2507-18
pubmed: 15923663
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Front Microbiol. 2020 Nov 13;11:611190
pubmed: 33281807
J Exp Med. 2004 Nov 1;200(9):1197-203
pubmed: 15520249
Mol Biochem Parasitol. 2014 Aug;196(1):29-40
pubmed: 25106850